Akili (AKLI) Stock Price, News & Analysis

Company Overview

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.

Key Stats

• Today's Range: $0.43 to $0.43
• 50-Day Range: $0.42 to $0.44
• 52-Week Range: $0.19 to $1.25
• Volume: N/A
• Average Volume: 2.20 million shs
• Market Capitalization: $34.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AKLI Stock Analysis - Frequently Asked Questions

How were Akili's earnings last quarter?

Akili, Inc. (NASDAQ:AKLI) released its quarterly earnings data on Thursday, May, 11th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.04. The company earned $0.11 million during the quarter. Akili had a negative net margin of 2,492.04% and a negative trailing twelve-month return on equity of 79.93%.
Read the conference call transcript.

What other stocks do shareholders of Akili own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akili investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), Taiwan Semiconductor Manufacturing (TSM), NVIDIA (NVDA), P3 Health Partners (PIII), uniQure (QURE) and Rolls-Royce Holdings PLC (RYCEY).

Company Calendar

• Last Earnings: 5/11/2023
• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AKLI
• CIK: 1850266
• Web: www.akiliinteractive.com
• Phone: 650-931-6236
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.61)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$59.49 million
• Net Margins: -2,492.04%
• Pretax Margin: -2,489.32%
• Return on Equity: -79.93%
• Return on Assets: -59.16%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 5.80
• Quick Ratio: 5.80

Sales & Book Value

• Annual Sales: $1.95 million
• Price / Sales: 17.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.75 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 78,727,000
• Free Float: 70,776,000
• Market Cap: $34.01 million
• Optionable: Optionable
• Beta: 1.72